Novel mechanism of action of corticosteroids in allergic diseases

May 19, 2009

Research by Peter Barnes (Imperial College, London) and colleagues may explain the effectiveness of common treatments for allergic inflammation and may point the way to targets for new treatments for allergic diseases, according to a study published in this week's open-access journal PLoS Medicine.

Allergic diseases - which affect about 50 million people a year in the US alone - are triggered when the immune system responds to a normally harmless material by activating a specific type of T lymphocyte called a T helper-2 cell (Th2). The Th2 cells make three , which are responsible for the inflammation associated with allergies. are often used to treat allergic inflammation but it is not well understood how these corticosteroids work to inhibit the expression of Th2 cytokines.

Using laboratory experiments and tests in seven patients with mild , Peter Barnes and colleagues suggest that corticosteroids inhibit the expression of Th2 cytokines and thus reduce allergic inflammation through two interacting mechanisms which both prevent the nuclear translocation of GATA-3, a key regulator of cytokine expression. Firstly, they suggest that corticosteroids compete with GATA-3 for binding to the nuclear import protein importin-α. Secondly, they suggest that corticosteroids prevent the phosphorylation of GATA-3, further preventing GATA-3 from binding to importin-α.

According to the authors, "This novel mechanism of action of corticosteroids may account for the striking clinical efficacy of corticosteroids in the treatment of allergic diseases", although further experiments are needed to show that the lymphocytes at the sites of allergic infection respond to corticosteroids in the same way as lymphocytes in the blood. In addition, these findings suggest that interaction between phosphorylated GATA-3 and importin-α may represent an important target for the development of new therapies for the treatment of .

More information: Maneechotesuwan K, Yao X, Ito K, Jazrawi E, Usmani OS, et al. (2009) Suppression of GATA-3 Nuclear Import and Phosphorylation: A Novel Mechanism of Corticosteroid Action in Allergic Disease. PLoS Med 6(5): e1000076. doi:10.1371/journal.pmed.1000076, medicine.plosjournals.org/perl… journal.pmed.1000076

Source: Public Library of Science (news : web)

Explore further: First successful vaccination against 'mad cow'-like wasting disease in deer

add to favorites email to friend print save as pdf

Related Stories

Allergic-like reactions occur in premedicated patients

Feb 09, 2008

Allergic-like reactions can occur in patients (both children and adults) when given gadolinium containing contrast agents, even if they have been pre-medicated with corticosteroids and antihistamines, according to a recent ...

Farm moms may help children beat allergies

May 20, 2008

Mothers exposed to farms, particularly to barns and farm milk, while pregnant confer protection from allergies on their newborns, according to a group of German researchers, who will present their findings at the American ...

New discovery may lead to new class of allergy drugs

Jan 29, 2009

If you've ever wondered why some allergic reactions progress quickly and may even become fatal, a new research report published in the February 2009 issue of the Journal of Leukocyte Biology provides an important part of the ...

Key Signaling Switch Identified in Allergic Disease

Oct 30, 2006

A research team has identified a key enzyme responsible for triggering a chain of events that results in allergic reaction, according to new study findings published online this week in Nature Immunology.

Recommended for you

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.